Navigation Links
Former Utah Governor to Talk About Her Battle With PF on ABC 4 Salt Lake City, July 22nd
Date:7/16/2009

Governor Walker to join University of Utah doctor on "Good Things Utah"

SAN JOSE, Calif., July 16 /PRNewswire-USNewswire/ -- Olene Walker has been interviewed by hundreds of reporters in her role as a politician, but an interview later this month will likely be the most compelling from the former Utah governor. Governor Walker, who served as Utah's governor from 2003 to 2005, will be sharing her personal struggle with a fatal lung disease.

Pulmonary Fibrosis (PF), a disease that will likely claim her life, has no known cause and no cure, and little name recognition outside of the patients and families who are affected. In an effort to change that, Gov. Walker will be appearing on ABC 4 Salt Lake City's Good Things Utah show on Wednesday, July 22, 2009 along with PF researcher and physician, Mary Beth Scholand, M.D. of the University of Utah School of Medicine.

Gov. Walker hopes her appearance on Good Things Utah will help inform people about PF, the severity of the diagnosis and the urgent need for treatments, though there may not be one in time to save her life.

"I am fighting for my life and the lives of so many others who are suffering from this horrible disease," said Olene Walker. "I am lucky to still be here and to be able to be a voice for so many who are struggling to breathe."

PF affects 128,000 Americans and claims 40,000 lives each year, the same as breast cancer. On average, patients live less than three years after diagnosis with the lung disease that is characterized by progressive and irreversible lung scarring.

"We are so thankful to Governor Walker for being willing to tell her story and allow the people of Utah and across the country to see this part of her life," said Mishka Michon, the CPF's CEO. "Her help in generating
'/>"/>

SOURCE Coalition for Pulmonary Fibrosis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
2. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
3. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
4. Former State Representative Terry Parke Joins Secure Services Corp.
5. Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
6. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, & Countrys Top Drug Treatment CEO Barry Karlin to Keynote Palm Beach, FL National Moment Of Change Intervention Conference:
7. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
8. Former HHS Secretary Dr. Louis Sullivan, Lt. Gov. Cagle Address Need to Improve Quality of Patient Care
9. Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione
10. Nobel Honors 3 Former March of Dimes Prize Recipients
11. Over one-third of former American football players had sexual relations with men, study says
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 411 More Children Die From Swine Flu 3A CDC 59676 111 More Children Die From Swine Flu 3A CDC 59676 211 More Children Die From Swine Flu 3A CDC 59676 3President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 1President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 2President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 3President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 4President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 5President Barack Obama Joins President George H W Bush to Celebrate the 20th Anniversary of the Points of Light Volunteer Movement and Extend the Cal 59671 6Peregrine Pharmaceuticals Announces Implementation of 1 3A5 Reverse Stock Split to Take Effect October 19 2009 59666 1Peregrine Pharmaceuticals Announces Implementation of 1 3A5 Reverse Stock Split to Take Effect October 19 2009 59666 2Peregrine Pharmaceuticals Announces Implementation of 1 3A5 Reverse Stock Split to Take Effect October 19 2009 59666 3Peregrine Pharmaceuticals Announces Implementation of 1 3A5 Reverse Stock Split to Take Effect October 19 2009 59666 4
Other Medicine Technology:Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 2Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 3Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 4Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 5Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7